MedTrace Logo

Atrial Fibrillation Detection: 24 Hour Study

NCT03507335 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 100

Last updated 2021-05-04

No results posted yet for this study

Summary

Aims Approximately 20-25% of strokes are of cardioembolic origin, atrial fibrillation (AF) being a significant cause of cardioembolic strokes. AF is often symptomless and intermittent, making its detection a clinical challenge. Currently the golden standard for diagnosis of AF is by 12-lead electrocardiogram (ECG) or any other ECG-strip.

The primary aim of the study is to assess the potential of chest strap as an ECG monitor especially in arrhythmia detection by cardiologist and algorithm. The secondary aim is to assess potential of photoplethysmography (PPG) based device for arrhythmia detection.

Conditions

Interventions

DEVICE

chest strap and PPG-device for monitoring the rhythm

chest strap and PPG-device for monitoring the rhythm during 24 hours for both groups (atrial fibrillation and sinus)

Sponsors & Collaborators

  • Kuopio University Hospital

    lead OTHER

Principal Investigators

  • Tero J Martikainen, PhD · Kuopio University Hospital

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2018-04-09
Primary Completion
2020-05-31
Completion
2020-08-31

Countries

  • Finland

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03507335 on ClinicalTrials.gov